Anagliptin Decreases Serum Lathosterol Level in Patients With Type 2 Diabetes: A Pilot Study
Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1517/14656566.2015.1057120
Full Text
Open PDFAbstract
Available in full text
Date
June 22, 2015
Authors
Publisher
Informa Healthcare